DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,332 | +0.1% | 3,251 | +10.8% | 0.00% | – |
| Q2 2023 | $41,289 | -2.3% | 2,934 | +7.2% | 0.00% | – |
| Q1 2023 | $42,271 | -40.6% | 2,737 | -36.8% | 0.00% | – |
| Q4 2022 | $71,147 | +58.1% | 4,331 | +78.0% | 0.00% | – |
| Q3 2022 | $45,000 | +50.0% | 2,433 | +4.3% | 0.00% | – |
| Q2 2022 | $30,000 | +36.4% | 2,333 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | 0.0% | 2,333 | +2.5% | 0.00% | – |
| Q4 2021 | $22,000 | -87.0% | 2,275 | -54.2% | 0.00% | – |
| Q3 2021 | $169,000 | +4.3% | 4,965 | +12.0% | 0.00% | – |
| Q2 2021 | $162,000 | +7.3% | 4,433 | +31.7% | 0.00% | – |
| Q1 2021 | $151,000 | +371.9% | 3,365 | +517.4% | 0.00% | – |
| Q4 2020 | $32,000 | +10.3% | 545 | 0.0% | 0.00% | – |
| Q3 2020 | $29,000 | +314.3% | 545 | +369.8% | 0.00% | – |
| Q2 2020 | $7,000 | -70.8% | 116 | -83.4% | 0.00% | – |
| Q1 2020 | $24,000 | – | 698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |